Related Experiment Video
Updated: Jul 7, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Diamond Blackfan anemia: a disorder of red blood cell development
Steven R Ellis1, Jeffrey M Lipton
1Department of Biochemistry and Molecular Biology, University of Louisville, Louisville, Kentucky, USA.
Insights
Diamond Blackfan anemia (DBA) is a rare inherited red blood cell disorder caused by mutations in ribosomal protein genes. Understanding DBA
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Diamond Blackfan anemia (DBA) is an inherited hypoplastic anemia presenting in infancy.
- Mutations in ribosomal protein genes are the primary cause of DBA, leading to haploinsufficiency.
- The disease's presentation timing suggests a link between defective ribosome synthesis and hematopoietic dysfunction around birth.
Purpose of the Study:
- To elucidate the molecular basis for the developmental timing of Diamond Blackfan anemia presentation.
- To explore how ribosomal protein haploinsufficiency affects various developmental pathways.
- To highlight the synergy between laboratory and clinical science in understanding DBA.
Main Methods:
- Review of genetic data from DBA patients.
- Analysis of molecular mechanisms underlying ribosomal protein haploinsufficiency.
- Correlation of clinical phenotypes with genetic modifiers.
Main Results:
- Identified mutations in ribosomal protein genes as causative for DBA.
- Hypothesized a link between defective ribosome synthesis and the hematopoietic phenotype around birth.
- Observed variable clinical presentations suggesting involvement of other developmental pathways influenced by modifier genes.
Conclusions:
- The developmental timing of DBA presentation is linked to defective ribosome synthesis impacting red blood cell production.
- Ribosomal protein haploinsufficiency can affect multiple developmental pathways, modulated by genetic factors.
- Integrated laboratory and clinical research offers enhanced insights into DBA and other human diseases.
Abstract:
Diamond Blackfan anemia (DBA) is an inherited hypoplastic anemia that typically presents in the first year of life. The genes identified to date that are mutated in DBA encode ribosomal proteins, and in these cases ribosomal protein haploinsufficiency gives rise to the disease. The developmental timing of DBA presentation suggests that the changes in red blood cell production that occur around the time of birth trigger a pathophysiological mechanism, likely linked to defective ribosome synthesis, which precipitates the hematopoietic phenotype. Variable presentation of other clinical phenotypes in DBA patients indicates that other developmental pathways may also be affected by ribosomal protein haploinsufficiency and that the involvement of these pathways is influenced by modifier genes. Understanding the molecular basis for the developmental timing of DBA presentation promises to shed light on a number of baffling features of this disease. This chapter also attempts to demonstrate how the marriage of laboratory and clinical science may enhance each and permit insights into human disease that neither alone can accomplish.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythropoiesis
Erythropoiesis
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

